Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Assessing Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis

18 years - 99 years
All genders
Interventional
This is an extension study for subjects over the age of 18, diagnosed with moderate-to-severe atopic dermatitis and enrolled in our main study IRB # 845325. This research study is being conducted to test the safety of lebrikizumab and potential side effects. Procedures include Physical exams, Medical History, blood and …
Learn More
An Open-Label Study For Continued Treatment Access For Participants From The B9991032 Avelumab Study

An Open-Label Study For Continued Treatment Access For Participants From The B9991032 Avelumab Study

18 years - 99 years
All genders
Phase 2
The purpose of the continuation sub-study is to provide continued treatment access for participants from the B9991032 Parent Study who are deriving benefit from study treatment as judged by the investigator.
Learn More

ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery

18 years - 99 years
All genders
The purpose of this study is to assess the safety of ALM-488, and to learn how well it shows nerve tissue in the body.
Learn More

Understanding the long-term impact of COVID on children and families

25 years or below
Accepts healthy volunteer
All genders
Observational
Purpose of this study is to understand why some people who got COVID-19 are still sick many months after being infected, and how this affects the body. This is sometimes called “Long COVID” or “PASC”, which stands for post-acute sequelae of SARS-CoV-2 infection. Children who have and have not had …
Learn More

Evaluating the Effect of Sage-718 on Cognitive Function in Participants with Huntington’s Disease

25 years - 65 years
All genders
Interventional
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
Learn More

Evaluating the Long-term Safety of Apraglutide in Short Bowel Syndrome

99 years or below
All genders
Interventional
The purpose of this extension trial is to find out how safe and how well the trial drug, apraglutide, is tolerated when you are treated for up to 104 weeks and to see if there are any changes in how much parenteral support (PS) you need.
Learn More

UPCC 15820: A Phase 3 Randomized Placebo-controlled Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

99 years or below
All genders
The purpose of this study is to see if niraparib added to a standard treatment (abiraterone acetate and prednisone) will work better than abiraterone acetate and prednisone alone in treating men with metastatic prostate cancer with specific genetic changes. Eligible subjects will be men with metastatic prostate cancer.
Learn More
A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas

A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas

18 years - 99 years
All genders
Phase 3
This study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real time detection and visualization of meningiomas during tumor resection surgery. Potential patients who sign informed consent will be screened for eligibility before receiving an oral solution of Gleolan 3 hours prior to …
Learn More
Evaluating Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis

Evaluating Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis

18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study is to evaluate how well the study drug (Navitoclax) works in combination with ruxolitinib when compared to best available therapy in subjects with Relapsed/Refractory Myelofibrosis.
Learn More

Study of Drug Serabelisib in Combination with an Insulin Suppressing Diet in Subjects with Cancer

18 years - 99 years
All genders
Phase 1
Interventional
The main purpose of this research is to try and find a better way to treat cancer. Specifically, this research will study how participants tolerate and might benefit from combining a special diet that is low in carbohydrates and high in fat with a drug intended to treat cancer (called …
Learn More
1111 - 1120 of 1243